Abstract
Objective: The objective of the present investigation was to improve the dissolution rate of Orlistat (ORL), a poor water-soluble anti-obesity drug by solid dispersion technique. Materials and Methods: To improve the solubility and dissolution, ORL solid dispersion was formulated using a hydrophilic polymeric carrier poloxomer 188. Solid dispersion was formulated by kneading method and physicochemical characterization and in vitro release study was carried out. Results: Fourier transform infrared spectral (FT-IR) and Differential scanning calorimetry (DSC) study showed a change in the crystalline nature of the drug, and its conversion into amorphous form. The in vitro dissolution study of physical mixture and solid dispersion both showed enhanced solubility as compared to the pure active drug. Conclusion: This study suggests that ORL solid dispersion having drug: Carrier (1:5) could be a promising approach to improve the solubility and dissolution.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
